Randomized Controlled Study to Assess the Efficacy of a Dietary Ingredient in Patients With Herniated Lumbar Disc Compression

NCT00405041 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2008-04-10

No results posted yet for this study

Summary

The objective of the study is to evaluate the efficacy of a neuroprotective dietary supplement in patients suffering from herniated lumbar disc causing nerve root compression.

Conditions

  • Herniated Disc

Interventions

DIETARY_SUPPLEMENT

Dietary supplement GVG 2

2.670 g/day for 14 days

Sponsors & Collaborators

  • Assaf-Harofeh Medical Center

    collaborator OTHER_GOV
  • Tel-Aviv Sourasky Medical Center

    lead OTHER_GOV

Principal Investigators

  • Samuel Dekel, M.D. · Tel Aviv Souraski Medical Center

  • Ory Keynan, M.D. · Tel Aviv Souraski Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2008-03-31
Completion
2008-04-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00405041 on ClinicalTrials.gov